The role of insulin pump therapy for type 2 diabetes mellitus

Zohar Landau; Itamar Raz; Julio Wainstein; Yosefa Bar‐Dayan; Avivit Cahn

doi:10.1002/dmrr.2822

journal article Jun 21, 2016

The role of insulin pump therapy for type 2 diabetes mellitus

Zohar Landau Itamar Raz

Julio Wainstein Yosefa Bar‐Dayan Avivit Cahn

Diabetes/Metabolism Research and Reviews Vol. 33 No. 1 · Wiley

View at Publisher Save 10.1002/dmrr.2822

Abstract

AbstractMany patients with type 2 diabetes fail to achieve adequate glucose control despite escalation of treatment and combinations of multiple therapies including insulin. Patients with long‐standing type 2 diabetes often suffer from the combination of severe insulin deficiency in addition to insulin resistance, thereby requiring high doses of insulin delivered in multiple injections to attain adequate glycemic control. Insulin‐pump therapy was first introduced in the 1970s as an approach to mimic physiological insulin delivery and attain normal glucose in patients with type 1 diabetes. The recent years have seen an increase in the use of this technology for patients with type 2 diabetes. This article summarizes the clinical studies evaluating insulin pump use in patients with type 2 diabetes and discusses the benefits and shortcomings of pump therapy in this population. Copyright © 2016 John Wiley & Sons, Ltd.

Topics

No keywords indexed for this article. Browse by subject →

References

76

[1]

IDF Diabetes Atlas ‐ 7th edition. Available at:http://www.diabetesatlas.org/last accessed on 22/5/2016.

[2]

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine 10.1056/nejm199309303291401

[3]

10.1056/nejmoa052187

[4]

10.1016/s0140-6736(98)07037-8

[5]

10.2337/dc08-9025

[6]

10.2337/diacare.26.11.3080

[7]

10.2337/dc11-0632

[8]

10.1185/03007990902973300

[9]

10.1089/dia.2012.0038

[10]

10.1056/nejmct1113948

[11]

10.2337/diacare.22.11.1779

[12]

10.1210/jc.2008-1415

[13]

10.1007/s00125-008-0974-3

[14]

10.2337/diacare.23.9.1232

[15]

10.1046/j.1464-5491.2002.00750.x

[16]

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial

Yves Reznik, Ohad Cohen, Ronnie Aronson et al.

The Lancet 10.1016/s0140-6736(14)61037-0

[17]

10.2337/dc10-zb01

[18]

"American Diabetes Association Approaches to glycemic treatment" Diabetes Care (2015)

[19]

10.1111/1753-0407.12321

[20]

10.1089/dia.2008.0128

[21]

10.1089/dia.2010.0110

[22]

10.1089/dia.2010.0034

[23]

10.1177/193229681100500410

[24]

10.1002/dmrr.849

[25]

10.1002/dmrr.2416

[26]

10.1097/smj.0b013e3181fa7230

[27]

10.1177/0145721710374369

[28]

10.2337/diacare.14.8.738

[29]

Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Therapy Are Equally Effective in Type 2 Diabetes

Philip Raskin, Bruce W. Bode, Jennifer B. Marks et al.

Diabetes Care 10.2337/diacare.26.9.2598

[30]

10.2337/diacare.28.7.1568

[31]

10.1111/j.1464-5491.2005.01597.x

[32]

Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen Failure

E. Berthe, B. Lireux, C. Coffin et al.

Hormone and Metabolic Research 10.1055/s-2007-970423

[33]

10.3892/etm.2014.1866

[34]

Conget I "The impact of insulin pump therapy on glycemic profiles in patients with type 2 diabetes: data from the OpT2mise study" Diabetes Technol Ther (2015)

[35]

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel et al.

New England Journal of Medicine 10.1056/nejmoa0806470

[36]

10.1056/nejmoa0706245

[37]

10.2337/dcs13-2014

[38]

10.2337/diacare.20.9.1353

[39]

10.1016/s2213-8587(13)70006-8

[40]

10.1016/s2213-8587(14)70136-6

[41]

Glaser B "Improved beta‐cell function after intensive insulin treatment in severe non‐insulin‐dependent diabetes" Acta Endocrinol (Copenh) (1988)

[42]

Park S "Induction of long‐term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy" Diabetes Metab Res Rev 10.1002/dmrr.343

[43]

10.1089/dia.2013.0078

[44]

10.3892/etm.2013.1300

[45]

10.1016/s2213-8587(15)00097-2

[46]

10.1507/endocrj.ej15-0160

[47]

10.1155/2016/9849328

[48]

10.1038/srep16968

[49]

10.1155/2016/6839735

[50]

10.2337/dc10-0355

Showing 50 of 76 references

Cited By

33

Automated Insulin Delivery Systems as a Treatment for Type 2 Diabetes Mellitus: A Review

Alexander B. Karol, Grenye O'Malley · 2023

Endocrine Practice

Metrics

33

Citations

76

References

Details

Published: Jun 21, 2016
Vol/Issue: 33(1)
License: View

Authors

Z

Zohar Landau

Pediatric Endocrine and Diabetes Unit E. Wolfson Medical Center Holon Israel; Sackler School of Medicine Tel Aviv University Tel Aviv Israel

I

Itamar Raz

Diabetes Unit, Department of Internal Medicine Hadassah University Hospital Jerusalem Israel

J

Julio Wainstein

Sackler School of Medicine Tel Aviv University Tel Aviv Israel; Diabetes Unit Wolfson Medical Center Holon Israel

Y

Yosefa Bar‐Dayan

Sackler School of Medicine Tel Aviv University Tel Aviv Israel; Diabetes Unit Wolfson Medical Center Holon Israel

A

Avivit Cahn

Diabetes Unit, Department of Internal Medicine Hadassah University Hospital Jerusalem Israel

Cite This Article

Zohar Landau, Itamar Raz, Julio Wainstein, et al. (2016). The role of insulin pump therapy for type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews, 33(1). https://doi.org/10.1002/dmrr.2822

The role of insulin pump therapy for type 2 diabetes mellitus

You May Also Like